Evidence map›Paper›PMID 36130727›Full record

ArticleNature2022

A designed photoenzyme for enantioselective [2+2] cycloadditions.

Jonathan S Trimble, Rebecca Crawshaw, Florence J Hardy, Colin W Levy, Murray J B Brown, Douglas E Fuerst, Derren J Heyes, Richard Obexer, Anthony P Green

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Nanomaterial Integration at Liquid-Liquid Interfaces for Green Catalysis.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Harnessing Photoenzymatic Systems for Intermolecular C-H Fluorination.Angewandte Chemie (International ed. in English) · 2026
    Article
  17. Article
  18. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  19. Fused 3D boron heterocyclesChemical science · 2026
    Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonathan S Trimble *Department of Chemistry, The University of Manchester, Manchester, UK.
Rebecca Crawshaw *Department of Chemistry, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-1574-6687
Florence J HardyDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0003-0671-0209
Colin W LevyDepartment of Chemistry, The University of Manchester, Manchester, UK.
Murray J B BrownSynthetic Biochemistry, Medicine Development and Supply, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.ORCID http://orcid.org/0000-0002-2393-7686
Douglas E FuerstSynthetic Biochemistry, Medicine Development and Supply, GlaxoSmithKline, Collegeville, PA, USA.
Derren J HeyesDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-7453-1571
Richard ObexerDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-4940-3543
Anthony P GreenDepartment of Chemistry, The University of Manchester, Manchester, UK. anthony.green@manchester.ac.uk.ORCID http://orcid.org/0000-0003-0454-1798

Funding

Biotechnology and Biological Sciences Research Council BB/M017702/1Biotechnology and Biological Sciences Research Council BB/M027023/1European Research Council 757991
6 · The paper itself

Abstract

The ability to program new modes of catalysis into proteins would allow the development of enzyme families with functions beyond those found in nature. To this end, genetic code expansion methodology holds particular promise, as it allows the site-selective introduction of new functional elements into proteins as noncanonical amino acid side chains

Indexed as

BiocatalysisCycloaddition ReactionEnzymesPhotochemical ProcessesAmino AcidsCatalytic DomainCrystallography, X-RayDrug DesignGenetic CodeStereoisomerismAmino AcidsEnzymes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.